Your browser doesn't support javascript.
loading
Very Long-Term Outcome of Non-Surgically Treated Patients with Temporal Lobe Epilepsy with Hippocampal Sclerosis: A Retrospective Study.
Kurita, Tsugiko; Sakurai, Kotaro; Takeda, Youji; Horinouchi, Toru; Kusumi, Ichiro.
Afiliação
  • Kurita T; Department of Psychiatry and Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Sakurai K; Department of Psychiatry and Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Takeda Y; Department of Psychiatry and Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Horinouchi T; Department of Psychiatry and Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Kusumi I; Department of Psychiatry and Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
PLoS One ; 11(7): e0159464, 2016.
Article em En | MEDLINE | ID: mdl-27415827
ABSTRACT

OBJECTIVE:

Surgical intervention can result in complete seizure remission rates of up to 80% in patients with temporal lobe epilepsy with hippocampal sclerosis (TLE-HS). However, certain patients cannot be treated surgically for various reasons. We analyzed the very long-term clinical outcomes of patients with TLE-HS who could not be treated surgically.

METHODS:

Subjects were selected from among patients with TLE-HS who were actively followed up for >10 years and treated with medication without surgical treatment. Patient medical records were used to retrospectively study seizure frequency, various clinical factors, and social adjustment. Patients who were seizure-free or had only aura were classified into Group 1; the others were classified into Group 2. Clinical factors including both patient and disease-specific factors were compared between the two groups. Current social adjustment, including the education, work, and economic status of each patient, was also investigated.

RESULTS:

Forty-one (41) subjects met the criteria for analysis, of which 12 (29%) were classified into Group 1. The average age of patients in Group 1 was higher than that of Group 2 (p = 0.0468). Group 2 included a significantly higher rate of patients who had more than one seizure per week at the onset (p = 0.0328), as well as a greater mean number of anti-epileptic drugs taken (p = 0.0024). Regarding social adjustment, Group 2 contained significantly fewer current jobholders than Group 1 (p = 0.0288).

CONCLUSIONS:

After very long-term follow-up periods, 29% of patients with TLE-HS had a good outcome through treatment with anticonvulsant medications. Older patients tended to have fewer seizures, and seizure frequency at the onset was the only factor that predicted outcome.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epilepsia do Lobo Temporal / Hipocampo / Anticonvulsivantes Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epilepsia do Lobo Temporal / Hipocampo / Anticonvulsivantes Idioma: En Ano de publicação: 2016 Tipo de documento: Article